发布时间:2019-04-23 17:47 原文链接: Radioiodinationofprotein

  • Radioiodination (by Jun Takagi,6/16/2000)

    Purpose and backgrounds
    Principle of radioiodination
    Addition of oxidizing reagents (such as chloramine-T or peroxidase+H202) converts I- to I+ or I3-. This highly reactive molecule attacks o-position of tyrosine (or in some case, histidine is also labeled).
    About nuclide...
    125-I
    decay: electron capture (g-ray, 0.035 MeV)
    half life: 60 days
    requires >3 mm lead plate to block >90% emission. Glass, plastic, or water cannot block.
    Chemical properties...
    Usually shipped as Na125I in alkaline solution at 1 mCi(37 MBq)/10µl.
    Easily evaporates when converted into molecular gas (I2) form. Therefore, you MUST NOT freeze the vial. Upon freezing, I2 will sublimate.
    *Always stabilize ionized form (I-) and avoid low pH and oxidizing condition for waste solution containing inorganic I-. To accomplish this, add 1/10 vol of stabilizer (see below) to the waste solution.
    Handling of Na125I soln in v-vial
    IODINE-125(Amersham; IMS30) will be shipped in v-vial with rubber septum. NEVER remove the septum! The solution must be taken out from the vial using Hamilton microsyringe with sharp needle.
















Materials
For procedure 1
• 0.1 M phosphate buffer, pH 7.0
• Tris-buffered saline (TBS)
• 5% BSA in TBS
• stabilizer soln (10% sodium thiosulfate+0.1N NaOH)
• IODO-BEAD™(PIERCE)
• Hamilton microsyringe (model 702, 25µl, needle gauge 22S, point style #2)
• desalting column (Bio-rad DG-10 etc.)
• column stand
For procedure 2
• PBS containing 20 mM glucose
• Hepes-Tyrode buffer (or any buffer compatible with your subsequent experiments with labeled cells)
• lactoperoxidase (Sigma L-8257) dissolved in PBS at 1 mg/ml
• glucose oxidase (Sigma G-7016) dissolved in PBS at 5 U/ml

Procedure
i) Radioiodination of protein in solution
*Reading a free booklet available from Amersham ("Guide to radioiodination techniques") is recommended.

1. In clear plastic tube, add 200µl of 0.1M phosphate buffer, pH 7
2. Add 5µl (500µCi) of 125-I using microsyringe
3. Add 1-2 pieces of IODO-BEADs
4. incubate at room temp, 5 min
5. Add your protein(1-100µg, 25 µg is good for IgGs or Fab)
6. Incubateat room temp, 10-25 min
7. Take reaction mixture (leave beads) and apply on a desalting column
§
8. Collect fractions (0.5 - 1 ml/fr.)

Prior to use, washed three times with phosphate buffer to remove debris on the beads)
§Block nonspecific binding site by applying 1ml of 5% BSA-TBS followed by equilibration with TBS.


















Typical result with Fab fragment labeling (50µg used)








Labeling efficiency (incorporation) should be 10-90% (depends on amount of protein added). Collect appropriate fraction (in this case, fr #3+4), add 1/4 vol of 5%BSA*, and store either at 4°C or -80°C in aliquots.

*addition of high conc. BSA will guard your dilute protein from decomposition by radiation, but should not added if it interfere with subsequent experiments. However, labeled and dilute protein without carrier protein tends to flocculate and easily loses its activity.

ii).Radioiodination of cell surface proteins

1. Wash cells at least three times with PBS and resuspend in 1 ml of PBS cntg. glucose at 0.5 - 2 x 107 cells/ml) in 15 ml conical tube, hold on ice
2. Add 5 - 50 µl (0.5 to 5 mCi) 125I using microsyringe
3. Add 50 µl of lactoperoxidase (1 mg/ml)
4. Add 10 µl of glucose oxidase (5 U/ml)
5. on ice, 5 min (occasionally agitate)
6. Add additional 10 µl of glucose oxidase (5 U/ml)
7. on ice, 5 min (occasionally agitate)
8. Add additional 10 µl of glucose oxidase (5 U/ml)
9. on ice, 5 min (occasionally agitate)
10. Add 6 ml of PBS (termination)
11. spin down the cells (1500 rpm, 3 min)*
*transfer the supernatant to waste bottle containing stabilizing solution
12. Wash 2 more times with PBS
13. Suspend the cells in appropriate buffer for solubilization of cell surface proteins
(successful experiments will result in 10 - 30% incorporation of 125I into cells)

References
1. "Guide to radioiodination techniques"free booklet available from Amersham
2. Marchalonis, Biochem. J., 113, 299 (1969)
3. Kramer et al, Cancer Res., 49, 393 (1989)




相关文章

因美纳推出Illumina®ProteinPrep,驱动更深入的蛋白质组学洞察,助力药物发现与开发

IlluminaProteinPrep可检测9,500种独特的人类蛋白质靶标,为蛋白质生物学提供全新洞察,推动疾病治疗新发现早期试用客户充分认可了其大规模检测能力、高度一致性以及简便的“从样本到洞察”......

科学家将人工智能技术成功用于蛋白质复合物结构预测

蛋白质作为构成人体组织器官的支架和主要物质,在人体生命活动中起着重要作用。蛋白质的相互作用能产生许多效应,如形成特异底物作用通道、生成新的结合位点、失活、作用底物专一性和动力学变化等,细胞的代谢、信号......

科学家将人工智能技术成功用于蛋白质复合物结构预测

蛋白质作为构成人体组织器官的支架和主要物质,在人体生命活动中起着重要作用。蛋白质的相互作用能产生许多效应,如形成特异底物作用通道、生成新的结合位点、失活、作用底物专一性和动力学变化等,细胞的代谢、信号......

发力癌症分子病理诊断,无锡臻和全资收购TissueofOrigin®

2021年9月9日,无锡臻和生物科技有限公司(以下简称“臻和科技”)与美国VyantBio公司签署TissueofOrigin®(以下简称“TOO®”)全球权益和ZL转让协议,全资收购这款唯一获FDA......

这3个杂志撤回中国学者249篇文章,包含上交、中山等名校

2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同时撤回了中国学者49篇文章。从2019年开始,Journalo......

ProteinCell:病毒感染时翻译后修饰乙酰化的动态调控

天然免疫应答是机体应对病原微生物入侵的第一道防线,在杀伤病原微生物、清除感染细胞和维持体内稳态等方面发挥关键作用。蛋白质翻译后修饰(proteinpost-translationalmodificat......

Protein&Cell丨刘平生团队发现脂滴和线粒体相互锚定接触

脂滴是一种具有中性脂质核心的膜性细胞器。与其他膜性细胞器的根本区别就是脂滴由单分子磷脂膜包被,而其他膜性细胞器由双分子磷脂膜与外界隔离。脂滴最早由列文虎克于1674年在牛奶里发现,是人类最早发现的膜性......

肿瘤治疗的强心剂,中国学者开发肿瘤治疗新策略

磷酸甘油酸突变酶1(PGAM1)通过其代谢活性以及与其他蛋白质(例如α平滑肌肌动蛋白(ACTA2))的相互作用,在癌症代谢和肿瘤进展中起关键作用。变构调节被认为是发现针对PGAM1的高选择性和有效抑制......

SCIEX携手ProteinMetrics公司实现生物制药AI及数据自动化

分析测试百科网讯随着生命科学产业的数字化转型和向精密医学的推进,集成以增强SCIEX高分辨率精确大众平台的快速数据处理能力继续推动数据需求。生命科学分析技术领域专业企业——SCIEX宣布与蛋白质特性质......

llumina宣布推出新型基因分型芯片|支持AllofUs研究计划

2018年12月6日,来自圣迭戈的消息——Illumina公司(纳斯达克股票代码:ILMN)今天宣布推出新型高密度基因分型芯片Infinium™GlobalDiversityArray。这款芯片设计源......